NeoGenomics (NEO) Competitors $7.98 -0.08 (-0.99%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$7.94 -0.04 (-0.44%) As of 09/5/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NEO vs. FTDR, WSC, HNGE, HRI, APLD, DLO, RELY, TNET, ATHM, and CARGShould you be buying NeoGenomics stock or one of its competitors? The main competitors of NeoGenomics include Frontdoor (FTDR), WillScot (WSC), Hinge Health (HNGE), Herc (HRI), Applied Digital (APLD), DLocal (DLO), Remitly Global (RELY), TriNet Group (TNET), Autohome (ATHM), and CarGurus (CARG). These companies are all part of the "business services" industry. NeoGenomics vs. Its Competitors Frontdoor WillScot Hinge Health Herc Applied Digital DLocal Remitly Global TriNet Group Autohome CarGurus Frontdoor (NASDAQ:FTDR) and NeoGenomics (NASDAQ:NEO) are both business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, profitability, risk and institutional ownership. Is FTDR or NEO more profitable? Frontdoor has a net margin of 13.07% compared to NeoGenomics' net margin of -15.10%. Frontdoor's return on equity of 125.21% beat NeoGenomics' return on equity.Company Net Margins Return on Equity Return on Assets Frontdoor13.07% 125.21% 15.65% NeoGenomics -15.10%-2.72%-1.54% Which has more volatility and risk, FTDR or NEO? Frontdoor has a beta of 1.34, suggesting that its stock price is 34% more volatile than the S&P 500. Comparatively, NeoGenomics has a beta of 1.62, suggesting that its stock price is 62% more volatile than the S&P 500. Does the media refer more to FTDR or NEO? In the previous week, Frontdoor had 1 more articles in the media than NeoGenomics. MarketBeat recorded 15 mentions for Frontdoor and 14 mentions for NeoGenomics. Frontdoor's average media sentiment score of 1.43 beat NeoGenomics' score of 0.90 indicating that Frontdoor is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Frontdoor 11 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive NeoGenomics 8 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, FTDR or NEO? Frontdoor has higher revenue and earnings than NeoGenomics. NeoGenomics is trading at a lower price-to-earnings ratio than Frontdoor, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFrontdoor$1.84B2.49$235M$3.3918.60NeoGenomics$689.19M1.50-$78.73M-$0.81-9.85 Do analysts rate FTDR or NEO? Frontdoor presently has a consensus price target of $59.75, suggesting a potential downside of 5.23%. NeoGenomics has a consensus price target of $13.22, suggesting a potential upside of 65.69%. Given NeoGenomics' higher probable upside, analysts clearly believe NeoGenomics is more favorable than Frontdoor.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Frontdoor 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.60NeoGenomics 0 Sell rating(s) 8 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.38 Do insiders and institutionals have more ownership in FTDR or NEO? 98.5% of NeoGenomics shares are held by institutional investors. 1.5% of Frontdoor shares are held by company insiders. Comparatively, 2.4% of NeoGenomics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryFrontdoor beats NeoGenomics on 12 of the 17 factors compared between the two stocks. Get NeoGenomics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NEO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEO vs. The Competition Export to ExcelMetricNeoGenomicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.04B$3.12B$5.77B$9.91BDividend YieldN/A2.29%6.71%4.52%P/E Ratio-9.8520.9775.5426.08Price / Sales1.50290.04480.4288.33Price / Cash18.3744.9736.9659.01Price / Book1.149.8611.446.09Net Income-$78.73M-$53.47M$3.28B$266.14M7 Day Performance-9.11%2.92%0.96%0.34%1 Month Performance45.36%9.83%7.82%4.42%1 Year Performance-50.25%15.97%62.64%26.17% NeoGenomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEONeoGenomics3.1672 of 5 stars$7.98-1.0%$13.22+65.7%-50.8%$1.04B$689.19M-9.852,200News CoverageAnalyst ForecastFTDRFrontdoor3.4555 of 5 stars$60.75+0.6%$59.75-1.6%+31.7%$4.43B$1.84B15.502,120Positive NewsWSCWillScot4.7429 of 5 stars$24.24-1.3%$36.00+48.5%-35.4%$4.41B$2.40B17.574,500Positive NewsHNGEHinge HealthN/A$56.30-2.5%$55.71-1.0%N/A$4.40BN/A0.001,514Analyst ForecastHRIHerc2.9796 of 5 stars$130.74-1.5%$144.60+10.6%+2.7%$4.35B$3.57B11.787,600Positive NewsAPLDApplied Digital3.0406 of 5 stars$15.98-3.7%$15.64-2.2%+158.7%$4.18B$144.19M0.00121Insider TradeGap UpDLODLocal2.4624 of 5 stars$14.46-0.7%$13.73-5.0%+56.4%$4.13B$745.97M24.511,095News CoverageRELYRemitly Global3.0038 of 5 stars$18.53+0.3%$29.00+56.5%+41.6%$3.82B$1.26B264.712,800Positive NewsInsider TradeTNETTriNet Group4.3873 of 5 stars$72.44+1.9%$96.33+33.0%-27.4%$3.52B$5.05B24.893,600ATHMAutohome3.8461 of 5 stars$28.84+1.4%$36.00+24.8%+4.5%$3.46B$964.42M16.974,415Positive NewsShort Interest ↓CARGCarGurus4.1291 of 5 stars$34.60+0.6%$38.13+10.2%+27.9%$3.43B$894.38M21.231,282Positive NewsAnalyst Downgrade Related Companies and Tools Related Companies Frontdoor Alternatives WillScot Alternatives Hinge Health Alternatives Herc Alternatives Applied Digital Alternatives DLocal Alternatives Remitly Global Alternatives TriNet Group Alternatives Autohome Alternatives CarGurus Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NEO) was last updated on 9/6/2025 by MarketBeat.com Staff From Our Partners6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWarren Buffett's Strangest AI InvestmentTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredOdd trade could help investors secure their wealth in 2025The most profitable phrase you’ve never heard of... Have you heard of 310F? This simple string of code coul...Eagle Publishing | SponsoredWall Street Legend Issues Urgent AI Stock Warning'Hidden AI' is taking the U.S. stock market by storm.Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeoGenomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeoGenomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
